Trade IVVD stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Invivyd, Inc. (IVVD) is trading at US$0.76, up 1.22% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$293.73M. Over the past 52 weeks, IVVD has traded between US$0.53 and US$3.07. On Syfe you can trade IVVD with $0 commission and add it to your watchlist.
| Previous close | US$0.75 |
|---|---|
| Market cap | US$293.73M |
| 52-week range | US$0.53 – US$3.07 |
| Volume | 6.25M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Invivyd, Inc.
Invivyd, Inc. engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The firm develops antibodies that can neutralize SARS-CoV-2, SARS-CoV-1, and additional emergent coronaviruses. It offers ADG20, a monoclonal antibody, targeting the spike protein of SARS-CoV-2 and related coronaviruses. The company was founded by Tillman U. Gerngross, Ren Russo and Laura Walker on June 3, 2020 and is headquartered in New Haven, CT.
Year: 2021
Invivyd Gets FDA Notice of Pemgarda COVID-19 Emergency Use Authorization Termination
Jul 6, 11:40 AM · MT Newswires
Invivyd's Late-Stage Trial of Covid Vaccine Alternative Completes Enrollment; Shares Rise Pre-Bell
Jun 16, 11:31 AM · MT Newswires
Invivyd Doses First Participants in Phase 3 Trial of COVID-19 Antibody VYD2311
Jun 9, 12:15 PM · MT Newswires
Invivyd Completes Enrolment in Phase 3 Symptomatic COVID-19 Trial
Jun 1, 11:44 AM · MT Newswires
Invivyd, Inc. (IVVD) stock is trading at US$0.76, +1.22% from the previous close of US$0.75.
The market cap for Invivyd, Inc. (IVVD) stock is approximately US$293.73M.
The 52-week high for Invivyd, Inc. (IVVD) stock is US$3.07.
The 52-week low for Invivyd, Inc. (IVVD) stock is US$0.53.
Invivyd, Inc. (IVVD) does not currently pay a dividend.
Stay on top of IVVD
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
